ZNF542P is a pseudogene associated with LDL response to simvastatin treatment

Statins are the most commonly prescribed cardiovascular disease drug, but their inter-individual efficacy varies considerably. Genetic factors uncovered to date have only explained a small proportion of variation in low-density lipoprotein cholesterol (LDLC) lowering. To identify novel markers and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyungpil, Theusch, Elizabeth, Kuang, Yu-Lin, Dose, Andrea, Mitchel, Katrina, Cubitt, Celia, Chen, Yii-Der I., Krauss, Ronald M., Medina, Marisa W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102286/
https://www.ncbi.nlm.nih.gov/pubmed/30127457
http://dx.doi.org/10.1038/s41598-018-30859-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102286/
https://www.ncbi.nlm.nih.gov/pubmed/30127457
http://dx.doi.org/10.1038/s41598-018-30859-y

Ejemplares similares